24/7 Wall StreetTue, 19 May 2026 20:19:54 GMTDitch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?ABBV+1.04%
Zacks Investment ResearchTue, 19 May 2026 14:01:28 GMTHere is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending StockABBV+1.04%
BenzingaTue, 19 May 2026 12:24:12 GMTWall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend YieldsABBV+1.04%
The Motley FoolTue, 19 May 2026 10:30:00 GMT2 High-Yield Healthcare Stocks to Buy Before They Raise PayoutsABBV+1.04%
Zacks Investment ResearchMon, 18 May 2026 17:20:43 GMTHere's How Neuroscience Drugs Boost AbbVie's Q1 Sales GrowthABBV+1.04%
Zacks Investment ResearchFri, 15 May 2026 17:41:13 GMTWhich Pharma Giant Offers Better Growth: AstraZeneca or AbbVie?ABBV+1.04%
Zacks Investment ResearchFri, 15 May 2026 16:01:09 GMTHow Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results?ABBV+1.04%
24/7 Wall StreetFri, 15 May 2026 15:40:36 GMTRealty Income Has Raised Its Dividend 113 Consecutive Times. Here Is Why That Is Not Enough to Own It Right NowABBV+1.04%
Seeking AlphaThu, 14 May 2026 00:30:49 GMTAbbVie Inc. (ABBV) Presents at Bank of America Global Healthcare Conference 2026 TranscriptABBV+1.04%
Zacks Investment ResearchWed, 13 May 2026 11:15:58 GMTThe Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and PrecipioABBV+1.04%
Seeking AlphaTue, 12 May 2026 14:30:09 GMTAbbVie's Growth Engine Is Firing On All CylindersABBV+1.04%
The Motley FoolMon, 11 May 2026 21:15:00 GMTA Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?ABBV+1.04%
Seeking AlphaMon, 11 May 2026 12:45:00 GMTAbbVie Q1: Skyrizi Delivers, Here's What Skeptics Are MissingABBV+1.04%
MarketBeatSat, 09 May 2026 14:08:50 GMTAbbVie Touts Record Sales and Pipeline Momentum at Annual MeetingABBV+1.04%
24/7 Wall StreetWed, 06 May 2026 14:32:31 GMT6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market CrashABBV+1.04%
The Motley FoolWed, 06 May 2026 08:10:00 GMTWant Reliable Dividend Income in May? These 2 Stocks DeliverABBV+1.04%
Zacks Investment ResearchTue, 05 May 2026 14:01:14 GMTIs Trending Stock AbbVie Inc. (ABBV) a Buy Now?ABBV+1.04%
The Motley FoolMon, 04 May 2026 20:30:00 GMTAbbVie's Latest Results Reveal a Trend Investors Shouldn't OverlookABBV+1.04%
The Motley FoolMon, 04 May 2026 20:26:23 GMT3 of the Best Dividend Stocks to Buy in May 2026ABBV+1.04%
